|
V60409
|
Atinumab (6A3-IgG4; ATI355) |
1226761-65-4 |
Atinumab (6A3-IgG4) is an antibody. |
|
V59365
|
Atisnolerbart |
2456308-79-3 |
Atisnolerbart is a human IgG4 antibody targeting BETVIA, the major birch pollen allergen Bet v 1-A. |
|
V58821
|
Baloramotide |
2207581-19-7 |
Baloramotide is a recombinant protein NY-ESO-1 containing 182 amino acid (AA)s. |
|
V56880
|
Balugrastim (CG 10639) |
527698-09-5 |
Balugrastim (CG 10639) is a new long-acting recombinant granulocyte colony-stimulating factor (G-CSF) obtained through the genetic fusion of recombinant human serum albumin and granulocyte colony-stimulating factor. |
|
V64547
|
Baminercept (BG 9924; TT-47) |
909110-25-4 |
Baminercept (BG 9924) is a lymphotoxin beta receptor IgG fusion protein (LTβR-Ig). |
|
V62134
|
Bapotulimab (BAY-1905254) |
2359413-58-2 |
Bapotulimab (BAY-1905254) is a fully human IgG2 antibody targeting immunoglobulin-like domain-containing receptor 2 (ILDR2). |
|
V64311
|
Batoclimab (HBM9161; IMVT-1401) |
2187430-05-1 |
Batoclimab is a human anti-FcRn monoclonal antibody (mAb). |
|
V64327
|
Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) |
648904-28-3 |
Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a phosphatidylserine (PS)-targeted monoclonal antibody (mAb) that can inhibit tumor growth by acting on tumor vasculature and reactivating anti-tumor immunity. |
|
V59475
|
Belrestotug (Berisutalumab; EOS-448; EOS884448; GSK4428859A) |
2574438-65-4 |
Belrestotug (EOS-448) is an antagonist anti-TIGIT (VSIG9, VSTM3) human immunoglobulin G1 kappa (hIgG1 kappa) antibody. |
|
V62556
|
Bempikibart (ADX-914) |
2622254-57-1 |
Bempikibart (ADX-914) is a human anti-IL-7Rα antibody. |
|
V62572
|
Bentracimab (PB 2452; MEDI 2452) |
2260568-31-6 |
Bentracimab (PB 2452) is a neutralizing monoclonal antibody (mAb) that binds Ticagrelor and its major active circulating metabolite with high affinity. |
|
V58882
|
Berlimatoxumab (ASN-2) |
1939109-24-6 |
Berlimatoxumab (ASN-2) is an antibody. |
|
V58524
|
Bevifimod (PRTX-100) |
2223113-32-2 |
Bevifimod (PRTX-100) is a highly purified Staphylococcal protein A (SpA). |
|
V64463
|
Bexmarilimab (FP-1305) |
2259301-27-2 |
Bexmarilimab (FP-1305) is a potent humanized anti-CLEVER-1 IgG4 antibody with IC50 of 4.51 nM. |
|
V60458
|
Bifikafusp alfa (L19-IL2) |
1957239-90-5 |
Bifikafusp alfa (L19-IL2) is an immunoresearch fusion protein consisting of the human L19 antibody fused to the human cytokine interleukin 2 (IL2). |
|
V64503
|
Bivatuzumab (BIWA 4; Anti-CD44 Recombinant Antibody) |
214559-60-1 |
Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody (mAb) targeting CD44v6. |
|
V62021
|
Bleselumab (ASKP 1240; Anti-Human CD40 Recombinant Antibody) |
1453067-91-8 |
Bleselumab (ASKP 1240) is a human anti-CD40 monoclonal antibody (mAb). |
|
V64460
|
Blosozumab |
1132758-87-2 |
Blosozumab (LY2541546) is an antibody inhibitor against human sclerostin (SOST). |
|
V59412
|
Bremzalerbart |
2456307-07-4 |
Bremzalerbart is a human IgG4 antibody targeting BETVIA, the major birch pollen allergen Bet v 1-A. |
|
V61956
|
Briquilimab (JSP-191) |
2574591-89-0 |
Briquilimab (JSP-191) is a nontoxic, humanized monoclonal antibody (mAb) targeting CD117 (c-Kit) for the depletion of hematopoietic stem cells (HSCs). |